Skip to content

Drug interactions

Glyburide + Osimertinib

Severity: Minor

Glyburide and Osimertinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Osimertinib inhibits BCRP in vitro and in clinical studies, and glyburide is partly handled by this transporter. Exposure to glyburide could increase slightly, with a greater chance of hypoglycemia. The clinical significance is likely small.

What this interaction means in plain words

Glyburide and Osimertinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Glyburide belongs to Endocrine; Osimertinib belongs to Oncology.

Evidence level: Low

Why it happens

Osimertinib inhibits BCRP-mediated efflux of glyburide.

What to do

Monitor blood glucose after starting osimertinib. Lower the glyburide dose if hypoglycemia appears.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glyburide and Osimertinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glyburide with Osimertinib?

MediHelp rates the interaction as minor. Glyburide and Osimertinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Osimertinib inhibits BCRP in vitro and in clinical studies, and glyburide is partly handled by this transporter. Exposure to glyburide could increase slightly, with a greater chance of hypoglycemia. The clinical significance is likely small.

How serious is the interaction between Glyburide and Osimertinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting osimertinib. Lower the glyburide dose if hypoglycemia appears.

What other medicines interact with Glyburide?

MediHelp also lists interactions of Glyburide with, for example, Bosentan, Cholic acid, Ciprofloxacin. The full list is on the Glyburide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in